In The News

Happy National Nurses Month - Webinar May 17

May 2, 2026

ANA’s free National Nurses Month webinar Asking and Advocating for What Nurses Need will present a case study on how nurses working collectively at the grassroots, state, and federal levels are effecting substantive changes in preventing workplace violence. Join us on May 17 at noon ET and earn 1.5 CNE. Register now.


Reminder: Webinar - How Economics Impact the Healthcare Industry

April 28, 2023

Macroeconomic Trends Influencing the Healthcare and Insurance Industries

Date: Wednesday, May 3rd, 2023
Time: 3:00 PM ET – 4:00pm ET
Duration: 1 hour*


It is important for all healthcare providers, including all nursing professionals, to possess an understanding of current healthcare market conditions, emerging trends, and risks that are affecting the healthcare industry. This presentation will discuss the key macroeconomic trends in the healthcare industry that are shifting the way healthcare practitioners provide professional and medical/clinical services. The presentation will also focus on how insurance providers are adapting to those trends and mitigating emerging risks related to the changing market environment.


  • Learn key market conditions affecting healthcare and insurance.
  • List top emerging trends in healthcare and insurance.
  • Identify key go-forward expectations nurses may see in healthcare practice beyond 2023.
Speaker Information:
  • Speaker: Bruce W. Dmytrow, BS, MBA, CPHRM, Senior Vice President, Global Healthcare Underwriting, CNA 
  • Moderator: Jennifer Flynn, CPHRM, Risk Manager, Nurses Service Organization (NSO)

Upcoming CNA Events & Meetings




Webinar May 10: Funding for Nursing Students & Nurses

April 25, 2023


ANA press release on the SCOTUS Decision in the Mifepristone

April 24, 2023

The American Nurses Association (ANA) is relieved that the U.S. Supreme Court has protected patient access to mifepristone, a medication used to treat a range of critical healthcare conditions including abortion. With this decision in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, mifepristone will remain widely available to individuals in the state of Texas and the FDA's decades-long approval of this safe and effective reproductive medication remains intact.  Please click here to read more.

<< first < Prev 1 2 3 4 5 6 7 8 9 10 Next > last >>

Page 10 of 122